The BioInsights Podcast  By  cover art

The BioInsights Podcast

By: BioInsights
  • Summary

  • The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.
    © 2024 The BioInsights Podcast
    Show more Show less
Episodes
  • Gene therapy is having a monumental year: how can the industry keep up with supply?
    Apr 4 2024

    Lauren Coyle, Commissioning Editor, Cell & Gene Therapy Insights, talks with Suman Subramanian, Head of Commercial Operations, Catalent Cell and Gene Therapy, to discuss the major achievements in the gene therapy market in 2023, with a focus on reliable manufacturing processes and strategies to enhance predictability while reducing waste in gene therapy manufacturing.

    Show more Show less
    24 mins
  • A deep dive in to generative AI applications in I-O
    Mar 18 2024

    Lauren Coyle, Commissioning Editor, Immuno-Oncology Insights, speaks with André Freitas, Senior Lecturer (University of Manchester) and Research Group Leader (Idiap Research Institute/National Biomarker Centre), about the intersection of generative AI and experimental cancer treatments, with a focus on clinical trials, regulatory considerations, and leveraging emerging technologies for a transformative impact in I-O.

    Show more Show less
    44 mins
  • Developing novel radioimmunotherapy combinations for lung cancer treatment
    Mar 12 2024

    Lauren Coyle, Commissioning Editor, Immuno-Oncology Insights, speaks to Joe Chang, Clinical Thoracic Oncologist, MD Anderson Cancer Center, University of Texas, who discusses his team’s pioneering work in combining radiation therapy with immunotherapy for lung cancer treatment. He highlights the challenges and promises of optimizing radioimmunotherapy combinations, emphasizing the importance of personalized treatment approaches and collaboration across disciplines to improve patient outcomes.

    Show more Show less
    15 mins

What listeners say about The BioInsights Podcast

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.